PRTK - Paratek Pharmaceuticals GAAP EPS of -$0.38 revenue of $30.2M November, 03 2022 04:26 PM Paratek Pharmaceuticals Inc. Paratek Pharmaceuticals press release ( NASDAQ: PRTK ): Q3 GAAP EPS of -$0.38. Revenue of $30.2M (+23.5% Y/Y). For further details see: Paratek Pharmaceuticals GAAP EPS of -$0.38, revenue of $30.2M